Parkinson’s Disease Therapeutics in Major Develope

Parkinson’s Disease Therapeutics in Major Develope'

Caption: Parkinson’s Disease Therapeutics in Major Developed Markets to 2021: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long-Acting Symptomatic Treatments

Credit: Market Research Reports, Inc.